
PB1787: GADD45A IS OVER‐EXPRESSED IN THE BONE MARROW OF PATIENTS WITH DE NOVO ACUTE MYELOID LEUKEMIA REFRACTORY TO INDUCTION CHEMOTHERAPY
Author(s) -
Bouchla A.,
Deliconstantinos G.,
Loupis T.,
Kontsioti F.,
Mpakou V.,
Delatola M.,
Pagoni M.,
Theodorakopoulos K.,
Papageorgiou S.,
Pappa V.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000850000.94525.1f
Subject(s) - cytarabine , idarubicin , myeloid leukemia , chemotherapy , leukemia , cancer research , bone marrow , induction chemotherapy , myeloid , medicine , biology , immunology